CL
RVMD icon

CSS LLC’s Revolution Medicines RVMD Stock Holding History

CSS LLC’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$408K Buy
+4,200
New +$424K 0.02% 579

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CSS LLC's RVMD Position: Q1 2026 in Review

CSS LLC sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 2,397 shares — an estimated $242K sold.

CSS LLC first reported a position in RVMD in Q4 2025 and held it in 1 quarter. The position peaked at $191K in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • CSS LLC reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • CSS LLC sold 2,397 Revolution Medicines shares in Q1 2026, an estimated $242K.
  • CSS LLC first reported a position in Revolution Medicines in Q4 2025 and held it in 1 quarter.
  • CSS LLC's Revolution Medicines position peaked at $191K in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.